ArticleCancer2021
Personalized lung cancer screening: Are we ready to ENGAGE?
Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Enhancing safety and therapeutic efficacy: PD-1 inhibitor and recombinant human endostatin combination in advanced non-small cell lung cancer patients.American journal of translational research · 2024Article
- Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis.Annals of internal medicine · 2023Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
lay summaryThe goal of delivering personalized lung cancer screening is a worthy one. It is inspiring to envision a future in which screening decisions are informed by the best available evidence, tailored to an individual's specific characteristics, and consistent with their preferences and values. At the societal level, tradeoffs between effectiveness, efficiency and equity are inevitable and will need to be balanced exquisitely, with ample input from patients and other stakeholders. Tools such as the ENGAGE framework will continue to enlighten and to shape the ongoing conversation.
Indexed as
Identifiers
34383308What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.